Virtu Financial’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-78,688
Closed -$57K 2430
2021
Q4
$57K Buy
78,688
+55,371
+237% +$44.8K 0.01% 1314
2021
Q3
$21K Buy
23,317
+8,883
+62% +$10.7K ﹤0.01% 1380
2021
Q2
$24K Sell
14,434
-27,510
-66% -$46K ﹤0.01% 1401
2021
Q1
$88K Buy
41,944
+19,471
+87% +$40.4K 0.01% 1350
2020
Q4
$28K Buy
+22,473
New +$26.8K ﹤0.01% 1331
2019
Q2
Sell
-10,716
Closed -$16K 2009
2019
Q1
$16K Buy
+10,716
New +$16.3K ﹤0.01% 1305
2017
Q4
Sell
-20,446
Closed -$24K 3207
2017
Q3
$24K Buy
+20,446
New +$23.3K ﹤0.01% 2324

Other funds holding MBII

Virtu Financial's MBII Position: Q1 2022 in Review

Virtu Financial sold out of Marrone Bio Innovations, Inc. (MBII) in Q1 2022, closing a stake of 78,688 shares — an estimated $57K sold.

Virtu Financial first reported a position in MBII in Q3 2017 and held it in 7 quarters. The position peaked at $88K in Q1 2021. 71 funds tracked by Wall St. Rank hold MBII as of Q1 2022.

  • Virtu Financial reported no remaining Marrone Bio Innovations, Inc. position as of Q1 2022 after selling out during the quarter.
  • Virtu Financial sold 78,688 Marrone Bio Innovations, Inc. shares in Q1 2022, an estimated $57K.
  • Virtu Financial first reported a position in Marrone Bio Innovations, Inc. in Q3 2017 and held it in 7 quarters.
  • Virtu Financial's Marrone Bio Innovations, Inc. position peaked at $88K in Q1 2021.
  • 71 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q1 2022.

Based on Virtu Financial's 13F filing for Q1 2022, filed 17 May 2022.